Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement

Dinesh Arab; Abutaher M. Yahia; Adnan I. Qureshi

doi:10.1080/14628840310003235

Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement

Dinesh Arab, Abutaher M. Yahia, Adnan I. Qureshi

Research output: Contribution to journal › Review article › peer-review

5 Scopus citations

Abstract

The benefit of intravenous abciximab as an adjunctive to percutaneous coronary intervention has been demonstrated in large-scale randomized studies. The role of intravenous abciximab is being defined in carotid angioplasty and stent placement as the procedure is gaining popularity for the treatment of high-grade carotid stenosis in patients considered high-risk for carotid endarterectomy. This paper summarizes the pathophysiological basis and the available data for the use of abciximab as an adjunct to carotid artery stenting.

Original language	English (US)
Pages (from-to)	61-66
Number of pages	6
Journal	International Journal of Cardiovascular Interventions
Volume	5
Issue number	2
DOIs	https://doi.org/10.1080/14628840310003235
State	Published - 2003
Externally published	Yes

Keywords

Abciximab
Angioplasty
Carotid stent
Hyperperfusion

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1080/14628840310003235

Find It

Find It at U of M Libraries

Cite this

@article{88ada72380bf4f329ede8ce058d52a7e,

title = "Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement",

abstract = "The benefit of intravenous abciximab as an adjunctive to percutaneous coronary intervention has been demonstrated in large-scale randomized studies. The role of intravenous abciximab is being defined in carotid angioplasty and stent placement as the procedure is gaining popularity for the treatment of high-grade carotid stenosis in patients considered high-risk for carotid endarterectomy. This paper summarizes the pathophysiological basis and the available data for the use of abciximab as an adjunct to carotid artery stenting.",

keywords = "Abciximab, Angioplasty, Carotid stent, Hyperperfusion",

author = "Dinesh Arab and Yahia, {Abutaher M.} and Qureshi, {Adnan I.}",

year = "2003",

doi = "10.1080/14628840310003235",

language = "English (US)",

volume = "5",

pages = "61--66",

journal = "International Journal of Cardiovascular Interventions",

issn = "1462-8848",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement

AU - Arab, Dinesh

AU - Yahia, Abutaher M.

AU - Qureshi, Adnan I.

PY - 2003

Y1 - 2003

N2 - The benefit of intravenous abciximab as an adjunctive to percutaneous coronary intervention has been demonstrated in large-scale randomized studies. The role of intravenous abciximab is being defined in carotid angioplasty and stent placement as the procedure is gaining popularity for the treatment of high-grade carotid stenosis in patients considered high-risk for carotid endarterectomy. This paper summarizes the pathophysiological basis and the available data for the use of abciximab as an adjunct to carotid artery stenting.

AB - The benefit of intravenous abciximab as an adjunctive to percutaneous coronary intervention has been demonstrated in large-scale randomized studies. The role of intravenous abciximab is being defined in carotid angioplasty and stent placement as the procedure is gaining popularity for the treatment of high-grade carotid stenosis in patients considered high-risk for carotid endarterectomy. This paper summarizes the pathophysiological basis and the available data for the use of abciximab as an adjunct to carotid artery stenting.

KW - Abciximab

KW - Angioplasty

KW - Carotid stent

KW - Hyperperfusion

UR - http://www.scopus.com/inward/record.url?scp=0037508894&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037508894&partnerID=8YFLogxK

U2 - 10.1080/14628840310003235

DO - 10.1080/14628840310003235

M3 - Review article

C2 - 12745860

AN - SCOPUS:0037508894

SN - 1462-8848

VL - 5

SP - 61

EP - 66

JO - International Journal of Cardiovascular Interventions

JF - International Journal of Cardiovascular Interventions

IS - 2

ER -

Use of intravenous abciximab as adjunctive therapy for carotid angioplasty and stent placement

Abstract

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this